These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19185682)

  • 1. Re: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Schilling LH
    Contraception; 2009 Mar; 79(3):241; author reply 241-2. PubMed ID: 19185682
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Pikkarainen E; Lehtonen-Veromaa M; Möttönen T; Kautiainen H; Viikari J
    Contraception; 2008 Sep; 78(3):226-31. PubMed ID: 18692613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serious adverse effect of combined oral contraceptive pills among teenagers].
    Nylander MC; Clausen HV
    Ugeskr Laeger; 2014 Jun; 176(26):V05130336. PubMed ID: 25294576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of the new contraceptive preparations.
    Clinch J
    Ir Med J; 1978 Oct; 71(15):513-4. PubMed ID: 711437
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogen dermatitis: treatment with progestin-only pill.
    Randall K; Steele R
    Arch Dermatol; 2005 Jun; 141(6):792-3. PubMed ID: 15967937
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Combination estrogen-progestin oral contraceptives.
    Petitti DB
    N Engl J Med; 2003 Oct; 349(15):1443-50. PubMed ID: 14534338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Venous pathology with estrogens-progestagens].
    Vin F; Allaert FA; Levardon M
    Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
    Loder EW; Buse DC; Golub JR
    Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception with estrogen and progestin combinations.
    Board JA
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
    [No Abstract]   [Full Text] [Related]  

  • 11. Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance.
    Mueck AO
    Menopause; 2010; 17(6):1099-103. PubMed ID: 20975607
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of oral contraceptives related to steroid content: a critical review.
    Sturtevant FM
    Int J Fertil; 1989; 34(5):323-32. PubMed ID: 2571592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium and bone metabolism across women's life stages. The effects of oral contraceptives/low dose estrogen-progestin on bone metabolism, bone mass and geometry in adolescent and young adult women.].
    Okano H
    Clin Calcium; 2017; 27(5):661-671. PubMed ID: 28439054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined oral contraceptives: a comprehensive review.
    Kiley J; Hammond C
    Clin Obstet Gynecol; 2007 Dec; 50(4):868-77. PubMed ID: 17982329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of arterial thrombosis increases with the use of combined oral contraceptives.
    Lidegaard Ø
    Evid Based Med; 2016 Feb; 21(1):38. PubMed ID: 26574484
    [No Abstract]   [Full Text] [Related]  

  • 16. Does the type of progestin influence the production of clotting factors?
    Stanczyk FZ; Mathews BW; Cortessis VK
    Contraception; 2017 Feb; 95(2):113-116. PubMed ID: 27421764
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose HRT may thwart bone loss. One form of low-dose HRT seems to preserve bone, but its safety remains uncertain.
    Runowicz CD
    Health News; 2003 Nov; 9(11):12-3. PubMed ID: 14619822
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological monitoring of oral estroprogestagen contraception].
    ANAES Agence nationale d'accréditation et d'evaluation en santé
    Gynecol Obstet Fertil; 2001 Mar; 29(3):254-6. PubMed ID: 11305289
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of hormonal contraception in adolescents: skeletal health issues.
    Tolaymat LL; Kaunitz AM
    Curr Opin Obstet Gynecol; 2009 Oct; 21(5):396-401. PubMed ID: 19491681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic estroprogestatives and phlebology. Introduction].
    Muller P
    Phlebologie; 1972; 25(3):223-6. PubMed ID: 4662045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.